1
EPISODE · Apr 16, 2026 · 14 MIN
FDA Seeks Additional Safety Data For Lilly GLP-1 Pill
from 1nessAgency Insights
The FDA has requested additional safety data from Eli Lilly for its oral GLP-1 medication, extending the approval timeline for what would be the first pill form of the blockbuster diabetes and weight loss drug class. For healthcare marketers who have spent 18 months watching GLP-1 demand outstrip su
Embed this episode
NOW PLAYING
FDA Seeks Additional Safety Data For Lilly GLP-1 Pill
0:00
14:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 1nessAgency Insights?
This episode is 14 minutes long.
When was this 1nessAgency Insights episode published?
This episode was published on April 16, 2026.
Can I download this 1nessAgency Insights episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!